A recent class action was filed in New York against the companies responsible for distributing or selling drugs containing tainted valsartan. The lawsuit, brought by a woman and her husband, alleges negligence, fraud, and manufacturing a defective product, among other claims.
Mass Torts Law Blog
The Mass Torts Law Blog, published by Stark & Stark, focuses on legal issues related to mass tort litigation involving defective medical devices, pharmaceuticals, and other product liability claims. The blog covers topics such as lawsuits and settlements for recalled implants like Exactech joint replacements, intrauterine devices like ParaGard, and medical devices including Philips Respironics CPAP machines. It also addresses vaccine injury compensation programs and related legal processes. The blog provides guidance on identifying potential claims, understanding litigation procedures including multidistrict litigation (MDL), and navigating complex mass tort cases.
Latest from Mass Torts Law Blog - Page 5
Global Settlement Order Entered as Abilify Litigation Moves Forward
In May 2018, Judge M. Casey Rogers, who is overseeing the federal Abilify litigation, entered an Order to establish the “initial parameters by which the global mediation of this matter will proceed.” The parties were given 120 days…
Gilead Facing Multiple Claims of Purposefully Delaying Safer HIV Drug Alternatives
It has been alleged that Gilead Sciences, an HIV drugmaker, purposefully delayed the introduction of safer, life-saving medications in order to increase profits.
In 2001, Gilead received approval for the sale of HIV drugs containing the compound, tenofovir disoproxil fumarate…
New Jersey Ethicon and Johnson & Johnson Hernia Mesh Cases: Parties Move for MCL Designation
There is a pending application in the Hernia Mesh litigation in New Jersey state court to have the litigation designated as a multicounty litigation (MCL). An MCL would permit centralized management of all related cases filed throughout New Jersey.
The…
New Jersey Abilify Cases Designated As an MCL
This month, the New Jersey Supreme Court designated the Abilify litigation in New Jersey a multicounty litigation (MCL). The Notice and Order can be found here: https://www.njcourts.gov/notices/2018/n180510b.pdf.
Though Bergen County Superior Court Judge James DeLuca had been overseeing all…
New Cialis Lawsuit Filed May Just Be the Beginning
On February 12th, a man from Arkansas filed a lawsuit against Eli Lily and Co., the manufacturers and distributors of the drug taladalafil, also known commercially as Cialis, alleging that the drug was the cause of his melanoma and that…
Invokana Cases Move Toward Trial in New Jersey
As previously discussed, in December 2016, the U.S. Judicial Panel on Multidistrict Litigation ordered Invokana cases consolidated into a Multi-District Litigation (MDL) in the United States District Court, District of New Jersey (MDL 2750).
Since the inception of the litigation, more than…
Diabetes Drug, Victoza, May Have Weight Loss Benefits, but Allegedly Linked to an Increase Risk of Pancreatic Cancer
Victoza (liraglutide), an injectable Type II diabetes drug, which works by stimulating insulin production by the pancreas, received approval from the U.S. Food and Drug Administration (“FDA”) in 2010.
When taken in high doses (3 milligrams), Victoza, manufactured by Novo…
Incretin Mimetics Cases See Signs of New Life on Appeal
As we have previously reported, safety concerns regarding incretin mimetics (such as Byetta, Januvia/Janumet and Victoza), led to more than a thousand lawsuits being filed across the country.
Reports suggest that people taking the medications for the treatment of Type…
New Jersey Abilify Cases: Parties Move for MCL Designation
In November 2017, counsel for plaintiffs and defendants in the Abilify litigation in New Jersey state court moved to have the litigation designated as a multicounty litigation (MCL).
As the New Jersey judiciary site notes, a “[m]ulticounty litigation may be…